Therapeutic Mechanism of Zhuyang Tongbian Decoction in Treating Functional Constipation: Insights from a Pilot Study Utilizing 16S rRNA Sequencing, Metagenomics, and Metabolomics

From BugSigDB
Reviewed Marked as Reviewed by Svetlana up on 2025-4-7
Citation
PMID PubMed identifier for scientific articles.
DOI Digital object identifier for electronic documents.
URI
Authors
Zhang X, Yin H, Yang X, Kang J, Sui N
Journal
International journal of general medicine
Year
2025
Keywords:
Zhuyang Tongbian Decoction, functional constipation, intestinal flora, intestinal inflammation, metabolite
PURPOSE: To explore the mechanism of Zhuyang Tongbian Decoction (ZTD) in treating functional constipation (FC) by observing its effects on intestinal flora composition, the metabolic function of gut microbiota, fecal short-chain fatty acid (SCFA) levels, and serum concentrations of TLR4, NF-κB, TNF-α, and IL-6 in patients with FC. PATIENTS AND METHODS: 40 patients with FC were randomly divided into the control group and the treatment group, 20 cases in each group. And 20 healthy volunteers were recruited during the same period. The control group was administered lactulose, while the treatment group was treated with ZTD. 16s RNA sequencing technology was used to compare the changes in the structure and diversity of the intestinal flora of patients before and after treatment. Changes in the levels of SCFAs in faeces and the levels of TLR4, NF-κB, TNF-α and IL-6 in serum were analysed. Metagenomics sequencing assessed microbiota metabolic functions. RESULTS: The treatment group showed a significant increase in the relative abundance of beneficial bacteria, including Bifidobacterium, Lactobacillus, and Faecalibacterium_prausnitzii (P < 0.05), whereas Desulfobacterota and Ruminococcus were significantly reduced (P < 0.05). Notably, fecal acetic and propionic acid levels were significantly higher in the treatment group (P < 0.05). Serum biomarkers TLR4, NF-κB, TNF-α, and IL-6 decreased significantly (P < 0.05). Metagenomics sequencing showed that Carbohydrate metabolism, Metabolism of cofactors and vitamins, and C5- Branched dibasic acid metabolism were significantly increased in functional abundance (P < 0.05). CONCLUSION: ZTD notably improves intestinal flora composition and gut microbiota metabolic function, regulates SCFA levels, and reduces inflammation markers in FC patients. The strain Faecalibacterium_prausnitzii shows significant potential in regulation of intestinal inflammation and may play a crucial role in the treatment efficacy of ZTD for FC.

Experiment 1


Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/21

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Feces Cow dung,Cow pat,Droppings,Dung,Excrement,Excreta,Faeces,Fecal material,Fecal matter,Fewmet,Frass,Guano,Matières fécales@fr,Merde@fr,Ordure,Partie de la merde@fr,Piece of shit,Porción de mierda@es,Portion of dung,Portion of excrement,Portion of faeces,Portion of fecal material,Portion of fecal matter,Portion of feces,Portion of guano,Portion of scat,Portionem cacas,Scat,Spoor,Spraint,Stool,Teil der fäkalien@de,Feces,feces
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Treatment outcome measurement Treatment outcome measurement,treatment outcome measurement
Group 0 name Corresponds to the control (unexposed) group for case-control studies
NC (Healthy Volunteers)
Group 1 name Corresponds to the case (exposed) group for case-control studies
FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction) group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
FC_PreZY group was treated with Zhuyang Tongbian Decoction (ZTD) (raw drug concentration: 3.0 g/mL)
Group 0 sample size Number of subjects in the control (unexposed) group
20
Group 1 sample size Number of subjects in the case (exposed) group
20
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
1 month

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.05
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No

Alpha Diversity

Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
decreased

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/21

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke

Source: Fig 2c

Description: Comparison of significantly different flora before and after treatment with ZTD at the genus level

Abundance in Group 1: increased abundance in FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction) group

NCBI Quality ControlLinks
Collinsella
Desulfovibrio
Romboutsia
Ruminococcus
UCG-002UCG-002
rumen bacterium NK4A214

Revision editor(s): PreciousChijioke

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/21

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke

Source: Fig 2c

Description: Comparison of significantly different flora before and after treatment with ZTD at the genus level

Abundance in Group 1: decreased abundance in FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction) group

NCBI Quality ControlLinks
Agathobacter
Faecalibacterium
Fusicatenibacter
Subdoligranulum
Christensenellaceae_R_7_groupChristensenellaceae_R_7_group

Revision editor(s): PreciousChijioke

Experiment 2


Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/21

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction) group
Group 1 name Corresponds to the case (exposed) group for case-control studies
ProZY (Pro-Zhuyang Tongbian Decoction) group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
FC_PreZY group after treatment with ZTD (raw drug concentration: 3.0 g/mL)

Lab analysis

Statistical Analysis

Alpha Diversity

Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
increased

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/21

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke

Source: Fig 2c

Description: Comparison of significantly different flora before and after treatment with ZTD at the genus level

Abundance in Group 1: increased abundance in ProZY (Pro-Zhuyang Tongbian Decoction) group

NCBI Quality ControlLinks
Agathobacter
Faecalibacterium
Fusicatenibacter
Subdoligranulum
Christensenellaceae_R_7_groupChristensenellaceae_R_7_group

Revision editor(s): PreciousChijioke

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/21

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke

Source: Fig 2c

Description: Comparison of significantly different flora before and after treatment with ZTD at the genus level

Abundance in Group 1: decreased abundance in ProZY (Pro-Zhuyang Tongbian Decoction) group

NCBI Quality ControlLinks
Collinsella
Desulfovibrio
Romboutsia
Ruminococcus
UCG-002UCG-002
rumen bacterium NK4A214

Revision editor(s): PreciousChijioke

Experiment 3


Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/22

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke, KateRasheed

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction) + ProZY (Pro-Zhuyang Tongbian Decoction)
Group 1 name Corresponds to the case (exposed) group for case-control studies
NC (Healthy volunteers)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Healthy volunteers with Bristol faecal character score of 4 according to the scoring criteria

Lab analysis

Statistical Analysis

Statistical test
LEfSe
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2


Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/22

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke, KateRasheed

Source: Fig 4

Description: Analysis of differential flora at different taxonomic levels

Abundance in Group 1: increased abundance in NC (Healthy volunteers)

NCBI Quality ControlLinks
Adlercreutzia
Agathobacter
Allisonella
Bacillota
Dialister
Dorea
Faecalibacterium
Faecalibacterium prausnitzii
Fusicatenibacter
Lachnoclostridium
Lachnospiraceae
Lachnospirales
Lactobacillaceae
Lactobacillus
Megamonas funiformis
Negativicutes
Oscillospiraceae
Roseburia
Ruminococcus gauvreauii
Veillonellaceae
gut metagenome
Veillonellales-SelenomonadalesVeillonellales-Selenomonadales

Revision editor(s): PreciousChijioke, KateRasheed

Experiment 4


Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/22

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke, KateRasheed

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
NC (Healthy volunteers) + ProZY (Pro-Zhuyang Tongbian Decoction)
Group 1 name Corresponds to the case (exposed) group for case-control studies
FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
FC_PreZY group was treated with ZTD (raw drug concentration: 3.0 g/mL)

Lab analysis

Statistical Analysis

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/22

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke, KateRasheed

Source: Fig 4

Description: Analysis of differential flora at different taxonomic levels

Abundance in Group 1: increased abundance in FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction)

NCBI Quality ControlLinks
Clostridia
Clostridiaceae
Colidextribacter
Collinsella
Coriobacteriaceae
Coriobacteriales
Coriobacteriia
Desulfovibrio
Desulfovibrionaceae
Desulfovibrionales
Desulfovibrionia
Eggerthellaceae
Erysipelotrichaceae
Erysipelotrichales
Holdemanella
Intestinibacter
Muribaculaceae
Oscillospiraceae
Peptostreptococcaceae
Romboutsia
Ruminococcus callidus
Senegalimassilia
Streptococcus equinus
Terrisporobacter
rumen bacterium NK4A214
UCG_002UCG_002
Eubacteriales
Eubacterium coprostanoligenes
Peptostreptococcales-TissierellalesPeptostreptococcales-Tissierellales
Thermodesulfobacteriota
Clostridium
UCG_005UCG_005
[Ruminococcus] torques

Revision editor(s): PreciousChijioke, KateRasheed

Experiment 5


Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/22

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke, KateRasheed

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
NC (Healthy volunteers) + FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction)
Group 1 name Corresponds to the case (exposed) group for case-control studies
ProZY (Pro-Zhuyang Tongbian Decoction)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
FC_PreZY group after treatment with ZTD (raw drug concentration: 3.0 g/mL)

Lab analysis

Statistical Analysis

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/23

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke, KateRasheed

Source: Fig 4

Description: Analysis of differential flora at different taxonomic levels

Abundance in Group 1: increased abundance in ProZY (Pro-Zhuyang Tongbian Decoction)

NCBI Quality ControlLinks
Bacteroides clarus
Butyricicoccaceae
Butyricicoccus
Christensenellaceae
Christensenellales
Lachnospira
Lactobacillales
Marinifilaceae
Oscillibacter
Paraprevotella
Streptococcaceae
Streptococcus
Streptococcus salivarius
Veillonella
Veillonella parvula
gut metagenome
Christensenellaceae_R_7_groupChristensenellaceae_R_7_group
UCG_008UCG_008
Clostridia UCG_014Clostridia UCG_014
Bacilli
Lachnospiraceae bacterium NK4A136
Lachnospira eligens
Prevotellaceae NK3B31 groupPrevotellaceae NK3B31 group
Enterococcaceae bacterium RF39
Lachnospiraceae UCG-001Lachnospiraceae UCG-001
[Eubacterium] siraeum

Revision editor(s): PreciousChijioke, KateRasheed

Experiment 6


Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/27

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke, KateRasheed

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
NC (Healthy Volunteers)
Group 1 name Corresponds to the case (exposed) group for case-control studies
FC_PreZY (Functional Constipation in Zhuyang Tongbian Decoction) group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
FC_PreZY group was treated with Zhuyang Tongbian Decoction (ZTD) (raw drug concentration: 3.0 g/mL)

Lab analysis

Statistical Analysis

Statistical test
Mann-Whitney (Wilcoxon)
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
Not specified

Alpha Diversity

Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
decreased

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/28

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke

Source: Fig 3a

Description: Comparison of the abundance of Bifidobacterium spp. and Lactobacillus spp. in each group

Abundance in Group 1: decreased abundance in FC_PreZY (Functional Constipation in Zhuyang Tongbian Decoction) group

NCBI Quality ControlLinks
Bifidobacterium
Lactobacillus

Revision editor(s): PreciousChijioke

Experiment 7


Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/28

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke, KateRasheed

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
FC_Prezy (Functional Constipation in Pre-Zhuyang Tongbian Decoction) group
Group 1 name Corresponds to the case (exposed) group for case-control studies
ProZY (Pro-Zhuyang Tongbian Decoction) group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
FC_PreZY group after treatment with ZTD (raw drug concentration: 3.0 g/mL)

Lab analysis

Statistical Analysis

Alpha Diversity

Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
increased

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/28

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke

Source: Fig 3a

Description: Comparison of the abundance of Bifidobacterium spp. and Lactobacillus spp. in each group

Abundance in Group 1: increased abundance in ProZY (Pro-Zhuyang Tongbian Decoction) group

NCBI Quality ControlLinks
Bifidobacterium
Lactobacillus

Revision editor(s): PreciousChijioke

Experiment 8


Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/28

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
NC (Healthy Volunteers)
Group 1 name Corresponds to the case (exposed) group for case-control studies
FC_PreCG (Functional Constipation in Pre-Control Group)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
FC_PreCG group was treated with lactulose (manufacturer: Fresenius Kabi Austria GmbH, Austria) orally

Lab analysis

Statistical Analysis

Alpha Diversity

Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
unchanged

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/29

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke

Source: Fig 3a

Description: Comparison of the abundance of Bifidobacterium spp. and Lactobacillus spp. in each group

Abundance in Group 1: decreased abundance in FC_PreCG (Functional Constipation in Pre-Control Group)

NCBI Quality ControlLinks
Bifidobacterium
Lactobacillus

Revision editor(s): PreciousChijioke

Experiment 9


Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/28

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke, KateRasheed

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
FC_PreCG (Functional Constipation in Pre-Control Group)
Group 1 name Corresponds to the case (exposed) group for case-control studies
ProCG (Post-Control Group)
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
FC_PreCG group after treatment with lactulose orally

Lab analysis

Statistical Analysis

Alpha Diversity

Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
increased

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/03/29

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke

Source: Fig 3a

Description: Comparison of the abundance of Bifidobacterium spp. and Lactobacillus spp. in each group

Abundance in Group 1: increased abundance in ProCG (Post-Control Group)

NCBI Quality ControlLinks
Bifidobacterium

Revision editor(s): PreciousChijioke

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/04/04

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke

Source: Fig 3a

Description: Comparison of the abundance of Bifidobacterium spp. and Lactobacillus spp. in each group

Abundance in Group 1: decreased abundance in ProCG (Post-Control Group)

NCBI Quality ControlLinks
Lactobacillus

Revision editor(s): PreciousChijioke

Experiment 10


Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/04/04

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
ProZY (Pro-Zhuyang Tongbian Decoction)

Lab analysis

Statistical Analysis

Alpha Diversity

Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
unchanged

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/04/04

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke

Source: Fig 3a

Description: Comparison of the abundance of Bifidobacterium spp. and Lactobacillus spp. in each group

Abundance in Group 1: increased abundance in ProCG (Post-Control Group)

NCBI Quality ControlLinks
Bifidobacterium

Revision editor(s): PreciousChijioke

Experiment 11


Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/04/04

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke, KateRasheed

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
NC (Healthy Volunteers)
Group 1 name Corresponds to the case (exposed) group for case-control studies
FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction) group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
FC_PreZY group was treated with ZTD (raw drug concentration: 3.0 g/mL)

Lab analysis

Statistical Analysis

Alpha Diversity

Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
increased

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/04/04

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke

Source: Fig 3c

Description: Comparison of significantly different flora before and after treatment with ZTD at the species level

Abundance in Group 1: increased abundance in FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction) group

NCBI Quality ControlLinks
uncultured bacterium

Revision editor(s): PreciousChijioke

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/04/05

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke

Source: Fig 3c

Description: Comparison of significantly different flora before and after treatment with ZTD at the species level

Abundance in Group 1: decreased abundance in FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction) group

NCBI Quality ControlLinks
Escherichia coli
Bifidobacterium adolescentis
Faecalibacterium prausnitzii
Bifidobacterium longum
Bifidobacterium pseudocatenulatum
gut metagenome

Revision editor(s): PreciousChijioke

Experiment 12


Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/04/04

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke, KateRasheed

Differences from previous experiment shown

Subjects

Group 0 name Corresponds to the control (unexposed) group for case-control studies
FC_PreZY (Functional Constipation in Pre-Zhuyang Tongbian Decoction) group
Group 1 name Corresponds to the case (exposed) group for case-control studies
ProZY (Pro-Zhuyang Tongbian Decoction) group
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
FC_PreZY group after treatment with ZTD (raw drug concentration: 3.0 g/mL)

Lab analysis

Statistical Analysis

Alpha Diversity

Faith Phylogenetic diversity, takes into account phylogenetic distance of all taxa identified in a sample
increased

Signature 1

Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/04/04

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke, KateRasheed

Source: Fig 3c

Description: Comparison of significantly different flora before and after treatment with ZTD at the species level

Abundance in Group 1: decreased abundance in ProZY (Pro-Zhuyang Tongbian Decoction) group

NCBI Quality ControlLinks
uncultured bacterium

Revision editor(s): PreciousChijioke, KateRasheed

Signature 2

Reviewed Marked as Reviewed by Svetlana up on 2025-4-7

Curated date: 2025/04/05

Curator: PreciousChijioke

Revision editor(s): PreciousChijioke, KateRasheed

Source: Fig 3c

Description: Comparison of significantly different flora before and after treatment with ZTD at the species level

Abundance in Group 1: increased abundance in ProZY (Pro-Zhuyang Tongbian Decoction) group

NCBI Quality ControlLinks
Bifidobacterium adolescentis
Bifidobacterium longum
Bifidobacterium pseudocatenulatum
Escherichia coli
Faecalibacterium prausnitzii
gut metagenome

Revision editor(s): PreciousChijioke, KateRasheed